Eurobio Scientific Société anonyme (EPA:ALERS)
France · Delayed Price · Currency is EUR 24.00
+1.20 (5.26%)
Apr 24, 2026, 2:08 PM CET
EPA:ALERS Revenue
In the year 2025, Eurobio Scientific Société anonyme had annual revenue of 169.00M EUR with 9.07% growth. Eurobio Scientific Société anonyme had revenue of 88.20M in the half year ending December 31, 2025, with 23.75% growth.
Revenue
169.00M
Revenue Growth
+9.07%
P/S Ratio
1.36
Revenue / Employee
444.74K
Employees
320
Market Cap
229.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 169.00M | 14.05M | 9.07% |
| Dec 31, 2024 | 154.95M | 24.30M | 18.60% |
| Dec 31, 2023 | 130.65M | -22.25M | -14.55% |
| Dec 31, 2022 | 152.90M | -32.42M | -17.49% |
| Dec 31, 2021 | 185.32M | -3.87M | -2.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Biosynex | 97.95M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.38M |
| Novacyt | 22.69M |
| Implanet | 12.47M |
| Mauna Kea Technologies | 8.18M |
| SpineGuard | 3.76M |